| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Leandro Valiengo | Q48233264 |
| P2093 | author name string | Orestes Vicente Forlenza | |
| Florindo Stella | |||
| P2860 | cites work | Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder | Q61465318 |
| Platelet MAO, personality and response to lithium prophylaxis | Q72779731 | ||
| Long-lasting cognitive impairment in unipolar major depression: a 6-month follow-up study | Q73507919 | ||
| How common is resistance to treatment in recurrent, nonpsychotic geriatric depression? | Q77072730 | ||
| Backward masking task performance in stable, euthymic out-patients with bipolar disorder | Q77077199 | ||
| Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity. | Q51893777 | ||
| Evidence for a late onset bipolar-I disorder sub-group from 50 years. | Q51950965 | ||
| The impact of depression on the well-being, disability and use of services in older adults: a longitudinal perspective. | Q51955815 | ||
| Cognitive and social functioning in recovery from depression: results from a population-based three-year follow-up. | Q51981656 | ||
| Depressive symptoms among older adults: long-term reduction after a physical activity intervention. | Q53849630 | ||
| Prevalence of bipolar disorder in a psychogeriatric population. | Q54647927 | ||
| The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepression | Q58479272 | ||
| Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication | Q22253034 | ||
| A molecular mechanism for the effect of lithium on development | Q24629067 | ||
| The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis | Q24651407 | ||
| Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update | Q28290363 | ||
| Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease | Q28570472 | ||
| A neurotrophic model for stress-related mood disorders | Q29616291 | ||
| A meta-analysis of cytokines in major depression | Q29617325 | ||
| Age differences in depression and anxiety symptoms: a structural equation modelling analysis of data from a general population sample. | Q30573642 | ||
| Neuropathological and neuromorphometric abnormalities in bipolar disorder: view from the medial prefrontal cortical network | Q30772377 | ||
| Resting state networks in major depressive disorder | Q30873337 | ||
| Diagnosis and biomarkers of predementia in Alzheimer's disease. | Q33777509 | ||
| Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders | Q33777958 | ||
| Depression in older adults | Q33781185 | ||
| Update on electroconvulsive therapy (ECT) in older adults | Q33919040 | ||
| Integrated neurobiology of bipolar disorder | Q34080310 | ||
| Cytokines in bipolar disorder: paving the way for neuroprogression. | Q34233926 | ||
| Prognosis of depression in old age compared to middle age: a systematic review of comparative studies | Q34447401 | ||
| Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis | Q34530360 | ||
| A systematic review and meta-analysis of magnetic resonance imaging studies in late-life depression | Q34560092 | ||
| Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial | Q34616063 | ||
| Treatment of bipolar disorder in older adults | Q34832733 | ||
| Depression in late life: review and commentary | Q35084435 | ||
| Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls | Q35758428 | ||
| A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force | Q36217653 | ||
| Exercise training and depression in older adults | Q36285520 | ||
| A comparative cross-cultural study of the prevalence of late life depression in low and middle income countries | Q36371691 | ||
| Glucocorticoids, cytokines and brain abnormalities in depression | Q36442019 | ||
| Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation | Q36667859 | ||
| Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders | Q36769080 | ||
| Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease | Q36825209 | ||
| rTMS deserves a fair chance as a novel treatment for depression | Q48315059 | ||
| Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. | Q48329873 | ||
| The vascular depression hypothesis: 10 years later | Q48343091 | ||
| Reduced serum nerve growth factor in patients with late-life depression | Q48487954 | ||
| Reduced serum levels of adiponectin in elderly patients with major depression. | Q48493746 | ||
| Mania compared with unipolar depression in old age. | Q48519162 | ||
| Brain single photon emission computed tomography findings in depressive pseudodementia patients | Q48557999 | ||
| White matter metabolism differentiates schizophrenia and bipolar disorder: a preliminary PET study | Q48921731 | ||
| Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder. | Q50541738 | ||
| Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. | Q50541776 | ||
| Malperformance in verbal fluency and delayed recall as cognitive risk factors for impairment in instrumental activities of daily living. | Q51023385 | ||
| Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. | Q51853704 | ||
| Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. | Q51857006 | ||
| Bipolar disorder in late life: clinical characteristics in a sample of older adults admitted for manic episode | Q36841515 | ||
| Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia | Q36991785 | ||
| Late-life depression symptom dimensions and cognitive functioning in the Longitudinal Aging Study Amsterdam (LASA). | Q37023082 | ||
| Cortical thickness, volume and surface area in patients with bipolar disorder types I and II | Q37026306 | ||
| Hippocampal volume and verbal memory performance in late-stage bipolar disorder | Q37175559 | ||
| Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression | Q37362345 | ||
| Neurobiological trait abnormalities in bipolar disorder | Q37489488 | ||
| Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder | Q37607009 | ||
| Brain imaging correlates of cognitive impairment in depression | Q37618560 | ||
| Patient choice as a driver of medication-switching in non-adherent individuals with bipolar disorder | Q37724206 | ||
| Intracellular pathways underlying the effects of lithium. | Q37779225 | ||
| Geriatric bipolar disorder | Q37871154 | ||
| Use of lithium in the treatment of bipolar disorder in late-life | Q37918851 | ||
| Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond | Q37928495 | ||
| Late-onset bipolar illness: the geriatric bipolar type VI. | Q37954400 | ||
| Cognitive impairment and dementia in bipolar disorder | Q38070544 | ||
| Risk-benefit analysis of antidepressant drug treatment in the elderly | Q38286201 | ||
| Changes in brain connectivity related to the treatment of depression measured through fMRI: a systematic review | Q38636784 | ||
| Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment | Q39045909 | ||
| Circulating Glial-derived neurotrophic factor is reduced in late-life depression | Q39465095 | ||
| 10-year trajectories of depressive symptoms and risk of dementia: a population-based study | Q39800532 | ||
| Neuroanatomy of Alzheimer's Disease and Late-Life Depression: A Coordinate-Based Meta-Analysis of MRI Studies. | Q41078666 | ||
| Bipolar mood disorders in the elderly. | Q41461251 | ||
| 'Vascular depression' hypothesis | Q41616775 | ||
| Bipolar disorder: similarities and differences between patients with illness onset before and after 65 years of age. | Q42690274 | ||
| Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial | Q43607222 | ||
| Risk factors for completed suicide in bipolar disorder. | Q44043993 | ||
| Maintenance treatment outcomes in older patients with bipolar I disorder | Q44094034 | ||
| Does lithium protect against dementia? | Q44119965 | ||
| Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials | Q44200928 | ||
| Nondysphoric depression following stroke | Q44226919 | ||
| Screening for bipolar disorder in the community | Q44318544 | ||
| Higher proportion of inactive Gsk3β in platelets of elderly patients with bipolar disorder: an effect of treatment? | Q44591494 | ||
| Subjective memory complaints in elders: depression, anxiety, or cognitive decline? | Q44676333 | ||
| The treated prevalence of bipolar disorder in a large staff-model HMO. | Q45017537 | ||
| Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial | Q45328463 | ||
| Lithium treatment and risk of dementia. | Q45940539 | ||
| Affective disorders in five United States communities | Q46057145 | ||
| Differences in clinical features and mental health service use in bipolar disorder across the lifespan | Q46103975 | ||
| HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients | Q46355630 | ||
| Lithium induced toxicity in rats: a hematological, biochemical and histopathological study | Q46466114 | ||
| Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial | Q46724462 | ||
| Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos | Q48178479 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mood disorder | Q188638 |
| P304 | page(s) | 2105-2114 | |
| P577 | publication date | 2016-08-24 | |
| P1433 | published in | Neuropsychiatric Disease and Treatment | Q15716332 |
| P1476 | title | Mood disorders in the elderly: prevalence, functional impact, and management challenges | |
| P478 | volume | 12 |
| Q47637596 | A randomized study on the effect of modified behavioral activation treatment for depressive symptoms in rural left-behind elderly |
| Q51766523 | Advances and Barriers for Clinical Neuroimaging in Late-Life Mood and Anxiety Disorders. |
| Q55285444 | Can Neutrophil Lymphocyte Ratio Predict the Likelihood of Suicide in Patients with Major Depression? |
| Q90609168 | Depressive disorders in the elderly and dementia: An update |
| Q47765380 | Drug repurposing may generate novel approaches to treating depression. |
| Q38742909 | Early Symptom Trajectories as Predictors of Treatment Outcome for Citalopram Versus Placebo |
| Q92638434 | Exploring Singapore's consumption of local fish, vegetables and fruits, meat and problematic alcohol use as risk factors of depression and subsyndromal depression in older adults |
| Q96299785 | Impact of SARS-CoV-2 pandemic on mental health in the elderly: perspective from a psychogeriatric clinic at a tertiary hospital in Sao Paulo, Brazil |
| Q96231334 | Occurrence of mood disorders among educationally active older adults in Bialystok, Poland: a cross-sectional study |
| Q92484287 | Organic mood disorder: Sequelae of small vessel disease |
| Q95315172 | Plasma redox and inflammatory patterns during major depressive episodes: a cross-sectional investigation in elderly patients with mood disorders |
| Q30369312 | Recommendations for the Use of ICT in Elderly Populations with Affective Disorders |
| Q42029100 | Risk Factors for Symptoms of Prescription Opioid Misuse: Do Older Adults Differ from Younger Adult Patients? |
| Q38658765 | Stress, depression, resilience and ageing: A role for the LPA-LPA1 pathway. |
| Q90080099 | The Bidirectional in Bilingual: Cognitive, Social and Linguistic Effects of and on Third-Age Language Learning |
| Q93122691 | The Forgotten Cells: Role of Astrocytes in Mood Disorders During the Aging |
| Q58788781 | The association between urinary Alzheimer-associated neuronal thread protein and cognitive impairment in late-life depression: a controlled pilot study |
| Q90117081 | Trends in multimorbidity, complex multimorbidity and multiple functional limitations in the ageing population of England, 2002-2015 |
Search more.